Inside the underground world of psychedelic therapy and the controversial charity pushing hard to bring the treatmentinto the mainstream.
Nine relative strangers are about to embark on a psychedelic voyage in bushland on Sydney's outskirts.
Their organiser is a self-styled guru offering healing and hope in the form of bags of green-grey powdered cactus dust the psychedelic drug mescaline.
The drug is illegal in Australia, but those here appear unfazed. They say the benefits are worth the risks.
Some are simply here for an adventure, but for many there's something deeper.
They're traumatised, struggling with life, and hoping to break through the pain.
"It's like a big reset on your brain," one participant, Jennyexplains.
"It's like you're a computer that's been going, going, going, going, going, and then you just push the reset button and then you kind of start again."
It's not her first time seeking healing through psychedelics but it's her first with mescaline. It's clear she's anxious.
She lines up with the others and quickly swallows a mix of gluggy cactus powder and organic apple juice. The group plans to hike through the national park until nightfall.
Within an hour, Jenny's feeling the effects.
"It's kind of a big reset on life," she offers.
"I think this medicine, what it does, it takes the logic away. You just get into your body and you forget what it's like being in your body because we fall into these " she trails off, staring into the distance.
"Ah, I can't do this." She's crying.
Around the country people like Jenny are being drawn to the hope and hype of psychedelic drugs like psilocybin (found in magic mushrooms), LSD and MDMA (commonly known as ecstasy).
The hope that psychedelics might hold the key to treating a range of mental health issues from anxiety to depression and PTSD isn't without merit. There are clinical trials happening around the world, including in Australia, which are showing promising results.
But some scientists say there's far more work to be done before these powerful drugs can be made safely available to the masses.
At a health and wellness retreat on the Sunshine Coast, investment banker Peter Hunt and his wife, opera singer Tania de Jong, have been fasting for several daysand are hoping to re-energise their mission.
Their psychedelic journey began on a trip to the Netherlands a few years earlier, where they ingested a large legal dose of psychedelic drugs known as "Psilohuascha" through a private therapist.
"It was wild," Peter says.
"It was like nothing I'd experienced before."
Tania describes it as "one of the most profound experiences in our lives".
It inspired them to found Australia's only registered charity advocating for the use of psychedelic therapy to treat mental illness, Mind Medicine Australia (MMA).
In just three years, they've established a for-profit training institute, a telephone hotline, and are lobbying to get psychedelics legalised for therapeutic use in clinical settings.
"We see a lot of people out there who are suffering, and we're determined to bring these therapies into the medical systemso psychiatrists can use them with their patients," Peter says.
But MMA is mired in controversy, with former staff alleging internal chaos, allegations of links to the underground, and claims it's used threats and intimidation to silence critics.
MMA's mission to get psychedelic therapy to the masses faces a major hurdle getting the drugs rescheduled by Australia's Therapeutic Goods Administration (TGA).
So far it's failed to clear that hurdle.
Tania says, with both state and federal regulations involved, the process has been complicated.
"And often, you're dealing with bureaucrats who are quite challenged by change," she says.
"Because you know, this is a paradigm shift."
The charity's TGA application would have allowed both MDMA and psilocybin to be used in therapeutic settings.
The application was drafted with the help of key scientific adviser Victor Chiruta, who until recently was listed on the charity's website under the heading "management team".
"Victor's got great scientific knowledge," Peter says.
Victor Chiruta is also a convicted drug cook.
Court documents obtained by Four Corners reveal earlier this year he pleaded guilty to manufacturing 57 grams of the drug MDA a similar drug to MDMA. He was arrested in 2014 after police allegedly discovered a commercial-scale illegal drug lab in the Blue Mountains.
"We are aware he's got difficulties, and we've given character references," Peter explains, noting Chiruta is also disabled after suffering burns to his body.
Tania tells Four Corners she's unconcerned about Victor's role at the charity.
"I'm not sure why you're making such a big thing of it, actually," she says.
"We're trying to focus on getting suffering people well, so this seems to be a bit of a red herring."
Despite the use of psychedelic drugs intherapy being illegal in Australia outside of strictly controlled trialsMMA has started running a training certificate for psychedelic therapists.
Tania says finding participants isn't a problem.
"Being a psychedelic-assisted therapist is probably one of the most popular and, I guess, sexy professions around at the moment," she says.
For $9,000, these hopeful psychedelic therapists can take a four-month, mostly online training course run by MMA's for-profit Mind Medicine Institute (MMI).
They receive MMI's Certificate of Psychedelic Assisted Therapy.
Melbourne psychotherapist Yury Shamis enrolled in the first intake, expecting an accredited course.
"[The] reality was, it was a good course, but it wasn't accredited at all. So the certificate really didn't mean anything," he said.
PhD student Kayla Greenstein enrolled last year, when the course was plagued with delays due to COVID.
"It was certainly presented as that if this became legal in Australia that Mind Medicine were the ones who would be certifying people.
"I recognise now that if I had spent more time on YouTube, I could have found a lot of the same information that I learned in that course, and I certainly didn't gain anything practical out of it.
"[I] ultimately decided to leave and I got a partial refund."
One of the issues raising eyebrows in the psychedelic community was a "major healthy persons trial" MMA announced it would be funding earlier this year, in which 200 participants would be able to "experience the medicines".
An email sent by the charity stated it had secured the MDMA for the trial and that "this trial will give graduates and participants in our Certificate of Psychedelic- Assisted Therapies (CPAT) Program the chance to actually undergo Psychedelic Assisted therapy in a clinically controlled environment".
Dr Emma Tumilty, a bioethicist from Deakin University, says that advertisement raised suspicions "that the research was in part being used as a vehicle to provide access to the drug so that MMA could offer training that included that experience".
"That would, of course, be ethically and scientifically inappropriate." she says.
The charity was eventually instructed to pull an advertisement for the study by the ethics committee that conditionally approved the trial. MMA says a "breach was innocently made".
After inquiries from Four Corners, the ethics committee advised the trial wasbeing withdrawn late last week.
Former MMA employees Diego Pinzon and his partner ScarletBarnett worked in fundraising and public relations at the charity.
Within weeks of starting in the job, they were called into a meeting with Tania de Jong after Scarletbecame upset at work.
The couple says she started asking whether Scarlethad any trauma or other issues.
"And then she suggested, 'Because if you do have abuse, you might consider MDMA therapy. I think that could be really beneficial for you. And here's someone you can call or put you in touch. You can set up a session with them'," Scarlet says.
Scarletclaims she wasgiven the number for Yury Shamis.
"He offered MDMA and psilocybin together as a session. And I think it would cost around $2,000," Scarlet recalls.
"He told me that if I did decide to go ahead, that I would need to let him know very soonbecause he books out about four months in advance."
Peter and Tania strongly deny they've ever referred anyone to underground psychedelic therapy and say they don't encourage people to break the law.
"We know there are good psychedelic therapists out there working in the underground. And yet, we can't refer these people to those people," Peter explains.
"Were we to do that, and were we to be caught in doing that, that would be the end of the charity."
Yury Shamis's therapy rooms sit above a share house in the Melbourne suburb of Balaclava. In the front yard, his sign has been defaced and reads "Dr Psycho Sham".
Yury is a psychotherapist which is not a legally protected title in Australia with a PhD in microbiology and a masters in counselling.
He says he got into psychedelics through "self-experimentation" for his own mental health struggles in the party scene.
"I noticed a lot of benefits. And I think when I became a therapist going into the psychedelic therapy kind of world was a no-brainer for me," he says.
Yury says he can be with patients who are on psychedelics, "technically if they've taken the drug before they've walked in", but chooses not to, and maintains he's not doing anything illegal.
On the windowsill in his office is an empty box of ketamine next to a hypodermic syringe packet.
His Facebook page was, until recently, public. There is a photo of a bag of white powder referred to in one of his posts as "K", and a pile of mushrooms with the caption "good day at the office".
In April 2021, Yury Shamis was listed online as one of the people MMA referred to callers who contacted their psychological support hotline.
A month later, he posted a status update: "that moment when you realise you've been taking peeps psychedelic virginity since your teens; and now you get paid for it".
At the time, MMA was fielding constant calls from desperate members of the public seeking psychedelic drugs for mental health treatment or information about where to get them.
The two head trainers and directors of the Mind Medicine Institute, Tra-ill Dowie and Nigel Denning, say they're concerned by "whispers" within the organisation of people being referred to underground psychedelic therapists, through the charity's hotline.
"If we're talking about a body and an organisation which is purporting clinical application, then there can be no room, in fact at all, for underground referrals or any of these kinds of things," Tra-ill says.
Nigelsays the idea of setting up the hotline was a disaster due to "the absence of any governance".
"There was an absence of any clarity about process and procedure, the absence of any security about referrals, and the absence of any vetting of how therapists within that process were treating, what they were treating," he explains.
The hotline was eventually shut down.
MMA's unconventional efforts to promote its cause have courted controversy.
Tania composed and performed a song promoting the effects of psilocybin titled Shroom Boom for a live cabaret performance called Songs for Psychedelics.
An accompanying music video was posted on the charity's YouTube channel this year.
Its lyrics include:
"Why can't I get out of bed. It's not because I am dead.
And yet the pain never stops antidepressants and side effects.
So I tried magic mushrooms and now I'm feeling so great.
Shroom boom magic, magic mushroom.
Taking us into a magical world of mushrooms.
Shroom boom. Mushrooms karma pharma."
Many in the scientific community felt the video was ill-advised and dangerous, promoting the use of psychedelics over antidepressants.
Dr Rosalind Watts, the former clinical lead of the Imperial College's Centre for Psychedelic Research, shared her concerns in the video's comments.
"Taking magic mushrooms to treat depression is a high-risk therapy that requires ongoing support from trained professionals. They do not magically reset the depressed brain, or heal the world, or the soul"
That commentmysteriously disappeared.
Former MMA employee Dr Alana Roy says on the charity's YouTube the video "received significant negative feedback, which were censored and edited".
Alana left the charity as the head of psychological services earlier this year after she raised concerns about the treatment of staff within the organisation.
"I was told by a senior member of Mind Medicine that if I continued to speak out, to expect litigation, and that if I did not tell them who else was speaking out, that I would face litigation as well," she says.
"They also told me in that meeting, that they had started to monitor my phone and emails and that they had hired the best technical investigator that they could find to monitor me."
See the original post:
The hope and hype of psychedelic therapy - ABC News
- Psychedelic Treatment with Psilocybin Relieves Major Depression, Study ... - February 20th, 2023
- Johns Hopkins Launches Center For Psychedelic Research - February 20th, 2023
- Psilocybin Treatment for Major Depression Effective for Up to a Year ... - February 20th, 2023
- Inside the Johns Hopkins Psilocybin Playlist - Hopkins Medicine - February 20th, 2023
- Research Story Tip: Psychedelic Drug Psilocybin Tamps Down Brains Ego ... - February 20th, 2023
- Psychedelics: Risks, benefits, and more - Medical News Today - February 18th, 2023
- Psychedelic Drug Effects, Side Effects & Dangers - January 25th, 2023
- Psychedelics Decriminalization Project In Berkeley, Cal Includes ... - January 6th, 2023
- Ancient mummified child was drugged with psychedelics before ritual ... - December 14th, 2022
- The therapeutic potential of psychedelics - Science - December 14th, 2022
- Changing Lives with Psychedelics: How Connecticut researchers are using magic mushrooms to help people overcome depression, OCD - WTNH.com - November 19th, 2022
- Penis Envy Mushroom | Legal Psychedelics | Magic Mushroom - November 7th, 2022
- Psychedelics. Discussing natural and synthetic friends. Science, News ... - November 5th, 2022
- The Harms of Psychedelics Need to Be Put Into Context - WIRED - November 5th, 2022
- Packers' Aaron Rodgers says psychedelics led to his back-to-back MVP ... - October 28th, 2022
- With Promise of Legalization, Psychedelic Companies Joust Over Future Profits - The New York Times - October 25th, 2022
- How do psychedelics work? This brain region may explain their effects - PBS - October 21st, 2022
- Why is the American right suddenly so interested in psychedelic drugs? - The Guardian - October 19th, 2022
- Can Psychedelics Cure? Science Is on the Verge of Finding Out - Newsweek - October 19th, 2022
- Large national survey suggests that the use of psychedelics is not associated with lifetime cancer development - PsyPost - October 19th, 2022
- This Pharma Company Just Scored Another Psychedelics Patent And Set Its Sights On 70 More - Small Pharma - Benzinga - October 19th, 2022
- What Made the Mushrooms Magic: Psychedelic Study Explores the Odd Evolution of Mind-Altering Fungi - The Debrief - October 19th, 2022
- Psychedelics And Wellness: The Healing Company Buys PepsiCo-Backed Superfoods Company - (HLCO) - Benzinga - October 19th, 2022
- What's on the Colorado ballot? Housing, psychedelics, school meals, alcohol, taxes and more | FOX31 Denver - FOX 31 Denver - October 19th, 2022
- DoseConnect to Sponsor the Tech Stage at Wonderland Miami by Microdose - Benzinga - October 19th, 2022
- What Is Going on With Bright Minds (DRUG) Stock Today? - InvestorPlace - October 19th, 2022
- Psychedelics May Ease Fear of Death and Dying - October 17th, 2022
- TDR's Top 5 Psychedelic Developments For The Week Of October 10 - The Dales Report - October 17th, 2022
- DEA Wants To Boost Production Of Cannabis & Psychedelics For Research In 2023 - Benzinga - October 17th, 2022
- Talk set to explore psychedelics and mental health - Reading Today - October 17th, 2022
- Silo Wellness Closes Acquisition of Dyscovry Science and Its Psilocybin Pharmaceutical Biosynthesis and Research Portfolio - Yahoo Finance - October 17th, 2022
- How does psilocybin rewire the brain? - Open Access Government - October 17th, 2022
- HYTN Awarded Controlled Drugs and Substances Dealers License Allowing for Production and Sale of Psilocybin - Yahoo Finance - October 17th, 2022
- The Healing Company acquires leading superfoods business, Your Super, and lands $150M credit facility to expand community of brands - Yahoo Finance - October 17th, 2022
- 5 Things to Know About Colorados Psychedelics Ballot Initiative - Kaiser Health News - October 15th, 2022
- Psilocybin Retreats - a Focal Point of the Growing Psychedelic Market - The Hype Magazine - October 15th, 2022
- 10 must-read weed and psychedelics books from the last decade - Leafly - October 15th, 2022
- Treating Postpartum Depression with Psychedelics - Psychedelic Spotlight - October 15th, 2022
- Clerkenwell Health raises 2.1M to test the new wave of psychedelics treatments - TechCrunch - October 15th, 2022
- Toronto Psychedelic Exhibition features the Art and History of Psychedelics - Psychedelic Spotlight - October 15th, 2022
- Elon Musk's 'Exploratory Journeys' And Charts Explaining Benefits Of Psychedelics Over Alcohol - Tesla (N - Benzinga - October 15th, 2022
- ALTRD.TV's Open Minds Documentary Explores the Promising Future of Psychedelic Medicine - Business Wire - October 15th, 2022
- IntelGenxs Collaboration with atai Life Sciences Culminates in the Initiation of First-in-Human Clinical Study of an Oral Thin Film Psychedelic Drug... - October 15th, 2022
- Psychedelics Companies And IPs: An Extended Patent Application To Protect Multiple LSD Derivatives - Bett - Benzinga - September 29th, 2022
- Congressman Says Psychedelics Show 'Real Promise' As Alternative Therapies At Committee Hearing - Marijuana Moment - September 29th, 2022
- Psychedelics and mental health: the potential, risks and hype - WHYY - September 27th, 2022
- Is Now a Good Time to Invest In Psychedelics Stocks? - The Motley Fool - September 27th, 2022
- I went to the only psychedelic dispensary in North Americaheres how they do it - The Manual - September 27th, 2022
- Psychedelic drugs: how to tell good research from bad - The Conversation Indonesia - September 27th, 2022
- The Connection Between Psychedelics and Grief - Psychedelic Spotlight - September 27th, 2022
- Effects of LSD and Psilocybin in Healthy Participants - Psychiatric Times - September 27th, 2022
- Cannabis And Psilocybin May Have Helped This Woman's Breast Cancer Treatment - IFLScience - September 27th, 2022
- Ketamine, psilocybin and ecstasy are coming to the medicine cabinet - Yahoo Finance - September 27th, 2022
- American Legion and Reality Center Partner to Provide Patented, Drug-Free Psychedelic Experience to Veter - Benzinga - September 27th, 2022
- Let's Bring the Informed Consent Process Out of the Shadows - Undark Magazine - September 27th, 2022
- Nicole Krauss on Death, Birth, and Middle Age - The New Yorker - September 27th, 2022
- Daily Skimm: Psychedelics, The DOJ, and iMessages - theSkimm - September 15th, 2022
- Inside the UK's new psychedelic drug trial clinic trying to treat depression and anxiety - iNews - September 15th, 2022
- What A Trip: Delix Therapeutics is Treating Mental Health at Scale with Psychoplastogens - Genetic Engineering & Biotechnology News - September 15th, 2022
- HealingMaps Announces $1 Million in Seed Funding to Power Growth in Psychedelic Therapy Industry - Yahoo Finance - September 15th, 2022
- Nav Talks The Moment He Realized He Made It; It Involves Psychedelics - UPROXX - September 15th, 2022
- Psychedelics and Psychedelic-Assisted Psychotherapy - September 7th, 2022
- Preparing for a new era of psychedelic treatment - The Hub at Johns Hopkins - September 7th, 2022
- Toronto is getting a trippy psychedelics immersive exhibition this month - Curiocity - September 7th, 2022
- Xtalks to host upcoming webinar on psychedelic know-how - Mugglehead - September 7th, 2022
- An immersive psychedelic exhibition is opening in Toronto this month | Listed - Daily Hive - September 7th, 2022
- Netflixs How to Change Your Mind Says Drugs Are the Answer Are They Right? - Goalcast - September 7th, 2022
- Yeah, Mental Health, Bro, It Starts With Self-Love | Aaron Rodgers Says His Use Of Psychedelics Has Increased His Passion For Life And The Game Of... - September 7th, 2022
- Delic Executive Chairman Matt Stang Named to World Biz Magazine's Top 100 CEOs in Innovation - Yahoo Finance - September 7th, 2022
- Cannabis and Hallucinogens Are Being Consumed at the Highest Rates on Record by Today's Young Adults - Cannabis Science and Technology - September 7th, 2022
- Aspen considers the value of psychedelics for mental wellness - The Aspen Times - August 29th, 2022
- Oregon's Psychedelics Law Comes Down To Individuals: Which Counties Will Ban Them? - Benzinga - August 29th, 2022
- The Black mothers finding freedom in mushrooms: They give us our power back - The Guardian - August 29th, 2022
- Psychedelic Water CEO Pankaj Gogia Talks About The Future Of Psychedelics - Exclusive - Health Digest - August 2nd, 2022
- Biden Administration Says Task Force Is Needed to Advance Psychedelics Research - Green Entrepreneur - August 2nd, 2022
- Legalizing the trip: One 'shroom advocate's playbook - POLITICO - August 2nd, 2022
- 'The result was a rebirth. I finally got where I wanted to go': Celebs who have tried psychedelics - The Daily Post-Athenian - August 2nd, 2022
- Texas' first Ceremonial Psychedelic Treatment Center WITHIN opens in Austin - PR Web - August 2nd, 2022
- Postdoctoral Research Fellow in Psychedelics, Neurodevelopment and Electrophysiology job with UNIVERSITY OF SYDNEY | 303322 - Times Higher Education - August 2nd, 2022
- Unlimited Sciences Announces Groundbreaking New Study to Observe Ayahuasca's Effects on Trauma - Business Wire - August 2nd, 2022